<DOC>
	<DOCNO>NCT01879683</DOCNO>
	<brief_summary>The purpose study evaluate LiRIS 400 mg safe tolerable administer woman Interstitial Cystitis Hunner 's lesion , evaluate change bladder IC symptom , follow LiRIS administration .</brief_summary>
	<brief_title>A Safety , Tolerability Preliminary Efficacy Study LiRISÂ® 400 mg Women With Interstitial Cystitis ( IC ) Hunner 's Lesions</brief_title>
	<detailed_description />
	<mesh_term>Cystitis</mesh_term>
	<mesh_term>Cystitis , Interstitial</mesh_term>
	<criteria>Women age 18 old Interstitial Cystitis history Hunner 's lesion bladder Moderate severe bladder discomfort Confirmation Hunner 's lesion Bladder Able report symptom ( pain void frequency ) diary throughout study Pregnant woman History presence bladder cancer History presence condition would make difficult evaluate bladder symptom</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Hunner 's lesion</keyword>
</DOC>